IBB vs QYLD

iShares Biotechnology ETF vs Global X Nasdaq 100 Covered Call ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.60% for QYLD.
  • QYLD pays a higher dividend yield (5.94%).

Side-by-side metrics

MetricIBBQYLD
Expense ratio
Annual fee. Lower is better.
0.44%0.60%
Dividend yield
Trailing 12-month yield.
0.22%5.94%
AUM
Assets under management — bigger funds are typically more liquid.
$9.09B$8.37B
YTD return
16.44%8.99%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.690.49
P/E ratio
24.7932.60
Last price
$196.62$18.40
Inception
Issuer
iSharesGlobal X

IBB top holdings

Top holdings · IBB
VRTXVertex Pharmaceuticals Inc8.07%
AMGNAmgen Inc7.82%
GILDGilead Sciences Inc6.83%
REGNRegeneron Pharmaceuticals Inc4.90%
ARGXargenx SE ADR3.75%
ALNYAlnylam Pharmaceuticals Inc3.12%
NTRANatera Inc2.89%
RVMDRevolution Medicines Inc Ordinary Shares2.78%
BIIBBiogen Inc2.46%
ILMNIllumina Inc2.07%
Sector breakdown · IBB
Healthcare100.0%

QYLD top holdings

Top holdings · QYLD
NVDANVIDIA Corp7.75%
AAPLApple Inc6.80%
MUMicron Technology Inc5.75%
MSFTMicrosoft Corp4.43%
AMDAdvanced Micro Devices Inc4.18%
AMZNAmazon.com Inc4.10%
TSLATesla Inc3.36%
GOOGLAlphabet Inc Class A3.33%
INTCIntel Corp3.10%
GOOGAlphabet Inc Class C3.08%
Sector breakdown · QYLD
Consumer Cyclical10.7%
Basic Materials1.0%
Consumer Defensive6.2%
Technology61.0%
Communication Services13.1%
Financial Services0.2%
Utilities1.1%
Industrials2.7%
Energy0.5%
Healthcare3.5%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About QYLD

QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.4B in assets under management, an expense ratio of 0.60%, a dividend yield of 5.94%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 10.7%.